US Patent Issued to GlaxoSmithKline Biologicals on Feb. 24 for "Mutated PglB oligosaccharyl transferase enzymes" (Swiss, American Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,731, issued on Feb. 24, was assigned to GlaxoSmithKline Biologicals SA (Rixensart, Belgium).

"Mutated PglB oligosaccharyl transferase enzymes" was invented by Leigh Anne Ihnken (Collegeville, Pa.), Joel Karpiak (Collegeville, Pa.), Stefan Jochen Kemmler (Schlieren, Switzerland), Michael Thomas Kowarik (Schlieren, Switzerland), Joel Melby (Collegeville, Pa.), Anne Ollis (Collegeville, Pa.) and Julien Laurent Quebatte (Schlieren, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides mutated PglB oligosaccharyltransferase enzymes that have the ability to efficiently catalyze the transfer of a saccharide from a lipid...